12:46 PM EST - Transition Therapeutics Inc. : has acquired the exclusive rights to three drug discovery projects from Forbes Medi-Tech Inc. in a deal worth between US$1 million and US$6 million. Forbes shares were unchanged at 94 cents while Transition Therapeutics Inc.
shares T.TTH are trading up 6 cents at $9.46.
